Fluid Biotech Revenue and Competitors

Calgary, AB CAN

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Fluid Biotech's estimated annual revenue is currently $3.6M per year.(i)
  • Fluid Biotech's estimated revenue per employee is $155,000

Employee Data

  • Fluid Biotech has 23 Employees.(i)
  • Fluid Biotech grew their employee count by 28% last year.

Fluid Biotech's People

NameTitleEmail/Phone
1
VP OperationsReveal Email/Phone
2
VP, Business DevelopmentReveal Email/Phone
3
Senior Quality EngineerReveal Email/Phone
4
Quality CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$3.6M467%$1.7MN/A
#3
$2.5M3214%N/AN/A
#4
$3.4M44-4%N/AN/A
#5
$11.8M7641%N/AN/A
#6
$3.6M23-4%N/AN/A
#7
$1.2M160%N/AN/A
#8
$4.5M29-9%N/AN/A
#9
$3.1M2033%N/AN/A
#10
$0.7M9-25%N/AN/A
Add Company

What Is Fluid Biotech?

Fluid Biotech is a start-up located in Calgary, Alberta. The company is developing an innovative brain stent to heal aneurysms. It represents years of research work from the laboratories at the University of Calgary.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$3.6M

Revenue (est)

28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Fluid Biotech News

2022-04-19 - Global Tumor Fluid Biopsy Market 2022 Emerging Trend and ...

Cellmax Life; Burning Rock Biotech; Berry Genomics Co; HaploX Biotechnology Co; New Horizon Health Limited; Genetronhealth; Amoy Diagnostics Co...

2022-04-19 - Instant Oral Fluid Testing Devices Market Size 2022-2029 ...

Instant Oral Fluid Testing Devices Market Size 2022-2029| Key Players – Abbott Laboratories, AccuBioTech, Guangzhou Wondfo Biotech, MEDACX Ltd.

2022-04-17 - Bayer nabs yet another oncology leader from GSK to bolster ...

Insight CXR Triage analyzes scans for presuspected conditions, such as a critical build-up of fluid or a collapsed lung. It then alerts clinicians of urgent...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M23-15%N/A
#2
$2.3M23-4%N/A
#3
$3M244%N/A
#4
N/A2450%N/A
#5
$5.5M24-14%N/A